1 Tobaldini E, Costantino G, Solbiati M et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neuroscience & Biobehavioral Reviews, Volume 74, Part B, 2017, Pages 321-329, ISSN 0149-7634, DOI: 10.1016/j.neubiorev.2016.07.004
2 Sweetman, Alexander. (2023). Co-morbid Insomnia and Sleep Apnoea (COMISA): Latest Research from an Emerging Field. Current Sleep Medicine Reports. 9. 1-10. 10.1007/s40675-023-00262-9)
3 ICD-10-GM Version 2023, Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification Stand: 06.12.2022.
4 American Psychiatric Association (Hrsg) (2013) DSM 5 (diagnostic and statistical manual ofmental disorders). American Psychiatric Association, Washington DC;
5 Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. SleepMed Rev6:97–111.
6 Riemann D, Baum E, Cohrs S et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen Kapitel „Insomnie bei Erwachsenen“ (AWMFRegisternummer 063-003), Update 2016, Somnologie 2017 21:2–44. DOI: 10.1007/s11818-016-0097-x Online publiziert: 27. Februar 2017 © Springer Medizin Verlag Berlin 2017.
7 Li M, Zhang X-W, Hou W-S, Tang Z-Y (2014) Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 176:1044–1047.
8 Meng L, Zheng Y, Hui R (2013). The relationship of sleepduration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res36:985–995.
9 Javaheri S, Redline S. Insomnia and Risk of Cardiovascular Disease. Chest. 2017 Aug;152(2):435-444. DOI: 10.1016/j.chest.2017.01.026. Epub 2017 Jan 30. PMID: 28153671; PMCID: PMC5577359.
10 Kim HO, Kang I, Choe W, Yoon KS. Sleep duration and risk of obesity: A genome and epidemiological study. WORLD ACADEMY OF SCIENCES JOURNAL 3: 20, 2021. DOI: 10.3892/wasj.2021.91.
11 Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med Rev. 2016 Dec;30:11-24. DOI: 10.1016/j.smrv.2015.10.002. Epub 2015 Oct 21. PMID: 26687279.
12 Yan B, Fan Y, Zhao B, He X, Yang J, Chen C, Ma X. Association between late bedtime and diabetes mellitus: A large community-based study. J Clin Sleep Med. 2019;15(11):1621–1627.
13 Yuanfeng Zhang, Xiaojiang Jiang, Juan Liu, Ying Lang, Yazhen Liu. The association between insomnia and the risk of metabolic syndrome: A systematic review and meta-analysis. Journal of Clinical Neuroscience 2021; 89:430-436, ISSN 0967-5868, DOI: 10.1016/j.jocn.2021.05.039).
14 Syauqy A, Hsu CY, Rau HH et al. Association of Sleep Duration and Insomnia Symptoms with Components of Metabolic Syndrome and Inflammation in Middle-Aged and Older Adults with Metabolic Syndrome in Taiwan. Nutrients 2019, 11, 1848. DOI: 10.3390/nu11081848
15 Sexton CE, Storsve AB, Walhovd KB et al. Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults. Neurology. 2014 Sep 9;83(11):967-73. DOI: 10.1212/WNL.0000000000000774. Epub 2014 Sep 3. PMID: 25186857; PMCID: PMC4162301.
16 Xie L, Kang H, Xu Q et al. Sleep drives metabolite clearance from the adult brain. Science. 2013 Oct 18;342(6156):373-7. DOI: 10.1126/science.1241224. PMID: 24136970; PMCID: PMC3880190
17 Reddy OC, van der Werf YD. The Sleeping Brain: Harnessing the Power of the Glymphatic System through Lifestyle Choices. Brain Sci. 2020 Nov 17;10(11):868. DOI: 10.3390/brainsci10110868. PMID: 33212927; PMCID: PMC7698404
18 Bellesi M, Pfister-Genskow M, Maret S et al. Effects of sleep and wake on oligodendrocytes and their precursors. J Neurosci. 2013 Sep 4;33(36):14288-300. DOI: 10.1523/JNEUROSCI.5102-12.2013. PMID: 24005282; PMCID: PMC3874087.
19 Holth JK, Fritschi SK, Wang C et al. The sleep-wake cycle regulates brain inters titial fluid tau in mice and CSF tau in humans. SCIENCE 2019; 363(6429):880-884 DOI: 10.1126/science.aav2546
20 Mayer G et al. Insomnie bei neurologischen Erkrankungen, S2k-Leitlinie, 2020, in: Deutsche Gesellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 06.02.2023).
21 Herkenrath, S., Schäfer, C. & Randerath, W. Endotypen und Phänotypen bei obstruktiver Schlafapnoe – aktuelle Diskussionen. Somnologie 28, 228–238 (2024) https://doi.org/10.1007/s11818-024-00482-3
22 American Academy of Sleep Medicine (2014) International classification of sleep disorders, (ICSD-3), 3. Aufl. American Academy of Sleep Medicine
23 Wiater A, Lehmkuhl G, Alfer D. Praxishandbuch Kinderschlaf. Elsevier 2020: 21-24; 50-54; 88-90.
24 Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). S3 Leitlinie Nicht erholsamer Schlaf/Schlafstörung Kapitel „Schlafbezogene Atmungsstörungen bei Erwachsenen“ 2017.AWMF-Register Nr. 063/001.
25 Orrù G, Storari M, Scano A, Piras V, Taibi R, Viscuso D. Obstructive Sleep Apnea, oxidative stress, inflammation and endothelial dysfunction-An overview of predictive laboratory biomarkers. Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6939-6948. doi: 10.26355/eurrev_202006_21685. PMID: 32633387
26 Schulz, R. (2025). Atherosklerose und Obstruktive Schlafapnoe. In: Peter, H., Penzel, T., Peter, J.H., Peter, J.G. (eds) Enzyklopädie der Schlafmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65186-5_239
27 Tamisier R, Weiss JW, Pépin JL. Sleep biology updates: Hemodynamic and autonomic control in sleep disorders. Metabolism 2018; 84:3-10. ISSN 0026-0495, DOI: 10.1016/j.metabol.2018.03.012.
28 Middeke M: Antihypertensive Chronotherapie. Grundlage renaler Hochdruckformen ist häufig ein gestörter Tag-Nacht-Rhythmus. Dialyse aktuell 14 (2) (2010) 98-103.
29 Gonçalves SC, Martinez D, Gus M et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007 Dec;132(6):1858-62. DOI: 10.1378/chest.07-1170. PMID: 18079220.
30 Fox H, Arzt M, Bergmann MW et al. Positionspapier „Schlafmedizin in der Kardiologie“, Update 2021. Kardiologe 15, 429–461 (2021). DOI: 10.1007/s12181-021-00506-4.
31 Jehan S, Farag M, Zizi F et al. Obstructive sleep apnea and stroke. Sleep Med Disord. 2018;2(5):120-125. Epub 2018 Nov 30. PMID: 30680373; PMCID: PMC6340906.
33 Tietjens JR, Claman AD, Kezirian AEJ et al. Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy. Journal of the American Heart Association 2019; 8:e010440. DOI:10.1161/JAHA.118.010440.
34 Wang X, Bi Y, Zhang Q, Pan F. Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Respirology. 2013 Jan;18(1):140-6. doi: 10.1111/j.1440-1843.2012.02267.x. PMID: 22988888.
36 Doumit J, Prasad B. Sleep Apnea in Type 2 Diabetes. Diabetes Spectr 1 February 2016; 29 (1): 14–19. DOI: 10.2337/diaspect.29.1.14.
37 Aurora RN, Punjabi NM. Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir Med. 2013 Jun;1(4):329-38. doi: 10.1016/S2213-2600(13)70039-0. Epub 2013 May 1. PMID: 24429158.
38 Xu H, Liang C, Zou J et al. Interaction between obstructive sleep apnea and short sleep duration on insulin resistance: a large-scale study. Respir Res 21, 151 (2020).
39 Chopra S, Rathore A, Younas H et al. Obstructive Sleep Apnea Dynamically Increases Nocturnal Plasma Free Fatty Acids, Glucose, and Cortisol During Sleep. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3172-3181. DOI: 10.1210/jc.2017-00619. PMID: 28595341; PMCID: PMC5587067
40 Almendros I, García-Río F. Sleep apnoea, insulin resistance and diabetes: the first step is in the fat. European Respiratory Journal Apr 2017, 49 (4) 1700179; DOI: 10.1183/13993003.00179-2017.
41 Borel AL, Tamisier R, Böhme P et al. Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened? Diabetes & Metabolism 2019; 45(2):91-101, ISSN 1262-3636, DOI: 10.1016/j.diabet.2018.08.006.
42 Rabinovich-Nikitin I, Lieberman B, Martino TA et al. Circadian-Regulated Cell Death in Cardiovascular Diseases. Circulation 2019; 139(7): 965-980. DOI:10.1161/CIRCULATIONAHA.118.036550.
43 Young ME, Bray MS. Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Med. 2007 Sep;8(6):656-67. DOI 10.1016/j.sleep.2006.12.010. Epub 2007 Mar 26. PMID: 17387040; PMCID: PMC2020822
44 Zhang Y, Ren R, Lei F, Zhou J, Zhang J, Wing YK, Sanford LD, Tang X. Worldwide and regional prevalence rates of co-occurrence of insomnia and insomnia symptoms with obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med Rev. 2019 Jun;45:1-17. doi: 10.1016/j.smrv.2019.01.004. Epub 2019 Feb 10. PMID: 30844624)
45 Sweetman, Alexander. (2023). Co-morbid Insomnia and Sleep Apnoea (COMISA): Latest Research from an Emerging Field. Current Sleep Medicine Reports. 9. 1-10. 10.1007/s40675-023-00262-938 Mason IC, Qian J, Adler GK et al. Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia 63, 462–472 (2020). DOI: 10.1007/s00125-019-05059-6.
46 Lechat, B., Appleton, S., Melaku, Y. A., Hansen, K., McEvoy, R. D., Adams, R. & Sweetman, A. (2022). The association of co‐morbid insomnia and sleep apnea with prevalent cardiovascular disease and incident cardiovascular events. Journal of Sleep Research, e13563.
47 Lechat, B., Appleton, S., Melaku, Y. A., Hansen, K., McEvoy, R. D., Adams, R. & Sweetman, A. (2022). Comorbid insomnia and sleep apnoea is associated with all-cause mortality. European Respiratory Journal, 60(1))
48 Zhang Y, Ren R, Lei F, Zhou J, Zhang J, Wing YK, Sanford LD, Tang X. Worldwide and regional prevalence rates of co-occurrence of insomnia and insomnia symptoms with obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med Rev. 2019 Jun;45:1-17. doi: 10.1016/j.smrv.2019.01.004. Epub 2019 Feb 10. PMID: 30844624)
49 diga.bfarm.de/de/verzeichnis ( aufgerufen am 17.6.2025)
